Uncategorized
Roche acquires ForSight Vision4
Roche Holdings Inc. has acquired ForSight Vision4, a developer of retinal disease drug delivery technology, according to a press release from ForSight Vision4.ForSight Vision4 previously entered a collaboration and license agreement for rights to its proprietary drug delivery technology for VEGF-A with Genentech, a member of the Roche Group.